Sumant Kulkarni's Stock Ratings

Canaccord Genuity Analyst

Sumant Kulkarni is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/20/2025

Overall Average Return

-11.6%

Smart Score

43%

Overall Average Return Percentile

19th

Number of Ratings

129
Buy NowGet Alert
03/18/2025CRVOBuy Now
CervoMed
$9.36124.36%
Sumant Kulkarni42%
$12 → $21MaintainsBuyGet Alert
03/13/2025ZVRABuy Now
Zevra Therapeutics
$7.95214.47%
Sumant Kulkarni42%
$23 → $25MaintainsBuyGet Alert
03/13/2025VYGRBuy Now
Voyager Therapeutics
$4.09193.4%
Sumant Kulkarni42%
$14 → $12MaintainsBuyGet Alert
02/28/2025CMPSBuy Now
Compass Pathways
$3.09385.44%
Sumant Kulkarni42%
$23 → $15MaintainsBuyGet Alert
02/13/2025BIIBBuy Now
Biogen
$141.4387.37%
Sumant Kulkarni42%
$298 → $265MaintainsBuyGet Alert
02/12/2025SAGEBuy Now
Sage Therapeutics
$8.25-3.03%
Sumant Kulkarni42%
$9 → $8MaintainsHoldGet Alert
02/12/2025CYBNBuy Now
Cybin
$7.50873.27%
Sumant Kulkarni42%
$86 → $73MaintainsBuyGet Alert
02/07/2025NBIXBuy Now
Neurocrine Biosciences
$109.7148.57%
Sumant Kulkarni42%
$172 → $163MaintainsBuyGet Alert
01/31/2025ITCIBuy Now
Intra-Cellular Therapies
$131.530.36%
Sumant Kulkarni42%
$119 → $132DowngradeBuy → HoldGet Alert
01/06/2025BTAIBuy Now
BioXcel Therapeutics
$2.34113.68%
Sumant Kulkarni42%
$112 → $80MaintainsBuyGet Alert
12/11/2024CRVOBuy Now
CervoMed
$9.3628.21%
Sumant Kulkarni42%
$65 → $12MaintainsBuyGet Alert
11/19/2024CYBNBuy Now
Cybin
$7.501046.59%
Sumant Kulkarni42%
$86 → $86MaintainsBuyGet Alert
11/18/2024GHRSBuy Now
GH Research
$11.78137.69%
Sumant Kulkarni42%
$31 → $28MaintainsBuyGet Alert
11/18/2024ATAIBuy Now
ATAI Life Sciences
$1.42674.65%
Sumant Kulkarni42%
$11 → $11MaintainsBuyGet Alert
11/14/2024ZVRABuy Now
Zevra Therapeutics
$7.95189.31%
Sumant Kulkarni42%
$25 → $23MaintainsBuyGet Alert
11/14/2024VYGRBuy Now
Voyager Therapeutics
$4.09242.3%
Sumant Kulkarni42%
$14 → $14MaintainsBuyGet Alert
11/14/2024CYBNBuy Now
Cybin
$7.501046.59%
Sumant Kulkarni42%
$96 → $86MaintainsBuyGet Alert
11/14/2024CLNNBuy Now
Clene
$4.501744.44%
Sumant Kulkarni42%
$86 → $83MaintainsBuyGet Alert
10/04/2024CLNNBuy Now
Clene
$4.501811.11%
Sumant Kulkarni42%
$94 → $86MaintainsBuyGet Alert
09/23/2024CYBNBuy Now
Cybin
$7.501179.91%
Sumant Kulkarni42%
$114 → $96MaintainsBuyGet Alert
09/18/2024ZVRABuy Now
Zevra Therapeutics
$7.95176.73%
Sumant Kulkarni42%
$24 → $22MaintainsBuyGet Alert
09/16/2024MNMDBuy Now
Mind Medicine
$6.70108.96%
Sumant Kulkarni42%
$16 → $14MaintainsBuyGet Alert
08/30/2024BTAIBuy Now
BioXcel Therapeutics
$2.34199.15%
Sumant Kulkarni42%
$112 → $112MaintainsBuyGet Alert
08/06/2024CLNNBuy Now
Clene
$4.501988.89%
Sumant Kulkarni42%
$94 → $94ReiteratesBuy → BuyGet Alert
08/02/2024CMPSBuy Now
Compass Pathways
$3.091453.4%
Sumant Kulkarni42%
$50 → $48MaintainsBuyGet Alert
07/25/2024CRVOBuy Now
CervoMed
$9.36594.44%
Sumant Kulkarni42%
$65 → $65MaintainsBuyGet Alert
06/27/2024BTAIBuy Now
BioXcel Therapeutics
$2.34199.15%
Sumant Kulkarni42%
$112 → $112MaintainsBuyGet Alert
06/20/2024ITCIBuy Now
Intra-Cellular Therapies
$131.53-14.09%
Sumant Kulkarni42%
$107 → $113MaintainsBuyGet Alert
06/13/2024CARABuy Now
Cara Therapeutics
$4.01-75.06%
Sumant Kulkarni42%
$120 → $12DowngradeBuy → HoldGet Alert
05/07/2024STOKBuy Now
Stoke Therapeutics
$8.28141.55%
Sumant Kulkarni42%
$21 → $20MaintainsBuyGet Alert
05/06/2024GHRSBuy Now
GH Research
$11.78163.16%
Sumant Kulkarni42%
$30 → $31MaintainsBuyGet Alert
05/02/2024NBIXBuy Now
Neurocrine Biosciences
$109.7149.49%
Sumant Kulkarni42%
$154 → $164MaintainsBuyGet Alert
04/30/2024ANVSBuy Now
Annovis Bio
$1.891275.66%
Sumant Kulkarni42%
$36 → $26MaintainsBuyGet Alert
04/26/2024SAGEBuy Now
Sage Therapeutics
$8.25106.06%
Sumant Kulkarni42%
$21 → $17MaintainsHoldGet Alert
04/23/2024ITCIBuy Now
Intra-Cellular Therapies
$131.53-18.65%
Sumant Kulkarni42%
$100 → $107MaintainsBuyGet Alert
04/08/2024CRVOBuy Now
CervoMed
$9.36594.44%
Sumant Kulkarni42%
$50 → $65MaintainsBuyGet Alert
03/26/2024STOKBuy Now
Stoke Therapeutics
$8.28153.62%
Sumant Kulkarni42%
$18 → $21MaintainsBuyGet Alert
03/14/2024BTAIBuy Now
BioXcel Therapeutics
$2.34199.15%
Sumant Kulkarni42%
$288 → $112MaintainsBuyGet Alert
03/12/2024ACADBuy Now
ACADIA Pharmaceuticals
$17.2990.86%
Sumant Kulkarni42%
$40 → $33MaintainsBuyGet Alert
03/06/2024CARABuy Now
Cara Therapeutics
$4.01149.38%
Sumant Kulkarni42%
$132 → $120MaintainsBuyGet Alert
02/23/2024ITCIBuy Now
Intra-Cellular Therapies
$131.53-23.97%
Sumant Kulkarni42%
$101 → $100MaintainsBuyGet Alert
02/20/2024BIIBBuy Now
Biogen
$141.43115.65%
Sumant Kulkarni42%
$310 → $305MaintainsBuyGet Alert
02/15/2024CRVOBuy Now
CervoMed
$9.36434.19%
Sumant Kulkarni42%
→ $50Initiates → BuyGet Alert
12/29/2023ANVSBuy Now
Annovis Bio
$1.891804.76%
Sumant Kulkarni42%
→ $36Initiates → BuyGet Alert
12/07/2023NBIXBuy Now
Neurocrine Biosciences
$109.7136.72%
Sumant Kulkarni42%
→ $150ReiteratesBuy → BuyGet Alert
11/08/2023ZVRABuy Now
Zevra Therapeutics
$7.95201.89%
Sumant Kulkarni42%
$20 → $24MaintainsBuyGet Alert
11/06/2023ACADBuy Now
ACADIA Pharmaceuticals
$17.29131.35%
Sumant Kulkarni42%
$38 → $40MaintainsBuyGet Alert
09/13/2023NBIXBuy Now
Neurocrine Biosciences
$109.7131.26%
Sumant Kulkarni42%
$132 → $144MaintainsBuyGet Alert
09/01/2023ZVRABuy Now
Zevra Therapeutics
$7.95151.57%
Sumant Kulkarni42%
$20 → $20ReiteratesBuy → BuyGet Alert
09/01/2023CYBNBuy Now
Cybin
$7.50-33.34%
Sumant Kulkarni42%
→ $190ReiteratesBuy → BuyGet Alert
08/22/2023CMPSBuy Now
Compass Pathways
$3.091518.12%
Sumant Kulkarni42%
$60 → $50MaintainsBuyGet Alert
08/16/2023ZYNEBuy Now
Zynerba Pharmaceuticals
Sumant Kulkarni42%
$10 → $1.11DowngradeBuy → HoldGet Alert
08/15/2023ZVRABuy Now
Zevra Therapeutics
$7.95151.57%
Sumant Kulkarni42%
$19 → $20MaintainsBuyGet Alert
08/15/2023BTAIBuy Now
BioXcel Therapeutics
$2.34754.7%
Sumant Kulkarni42%
$1216 → $320MaintainsBuyGet Alert
08/11/2023CYBNBuy Now
Cybin
$7.50-33.34%
Sumant Kulkarni42%
$228 → $190MaintainsBuyGet Alert
08/08/2023SAGEBuy Now
Sage Therapeutics
$8.25154.55%
Sumant Kulkarni42%
$64 → $21DowngradeBuy → HoldGet Alert
08/03/2023ACADBuy Now
ACADIA Pharmaceuticals
$17.29119.78%
Sumant Kulkarni42%
$39 → $38MaintainsBuyGet Alert
08/02/2023NBIXBuy Now
Neurocrine Biosciences
$109.7120.32%
Sumant Kulkarni42%
$130 → $132MaintainsBuyGet Alert
07/17/2023ACADBuy Now
ACADIA Pharmaceuticals
$17.29125.56%
Sumant Kulkarni42%
$28 → $39MaintainsBuyGet Alert
07/03/2023CYBNBuy Now
Cybin
$7.50-20.01%
Sumant Kulkarni42%
$266 → $228MaintainsBuyGet Alert
06/12/2023BIIBBuy Now
Biogen
$141.43147.47%
Sumant Kulkarni42%
$330 → $350MaintainsBuyGet Alert
05/10/2023VYGRBuy Now
Voyager Therapeutics
$4.09242.3%
Sumant Kulkarni42%
$10 → $14MaintainsBuyGet Alert
05/04/2023NBIXBuy Now
Neurocrine Biosciences
$109.7118.49%
Sumant Kulkarni42%
$132 → $130MaintainsBuyGet Alert
04/26/2023BIIBBuy Now
Biogen
$141.43133.33%
Sumant Kulkarni42%
$325 → $330MaintainsBuyGet Alert
04/26/2023STOKBuy Now
Stoke Therapeutics
$8.28189.86%
Sumant Kulkarni42%
→ $24Assumes → BuyGet Alert
03/30/2023NBIXBuy Now
Neurocrine Biosciences
$109.7120.32%
Sumant Kulkarni42%
$124 → $132UpgradeHold → BuyGet Alert
03/29/2023ITCIBuy Now
Intra-Cellular Therapies
$131.53-25.49%
Sumant Kulkarni42%
$93 → $98MaintainsBuyGet Alert
03/14/2023ACADBuy Now
ACADIA Pharmaceuticals
$17.2950.38%
Sumant Kulkarni42%
$24 → $26MaintainsBuyGet Alert
03/07/2023CARABuy Now
Cara Therapeutics
$4.01523.44%
Sumant Kulkarni42%
$348 → $300MaintainsBuyGet Alert
11/11/2022BTAIBuy Now
BioXcel Therapeutics
$2.343147.86%
Sumant Kulkarni42%
$1200 → $1216MaintainsBuyGet Alert
10/04/2022CLNNBuy Now
Clene
$4.5033.33%
Sumant Kulkarni42%
$200 → $120MaintainsBuyGet Alert
09/15/2022KMPHBuy Now
KemPharm
Sumant Kulkarni42%
→ $20Initiates → BuyGet Alert
06/23/2022ZYNEBuy Now
Zynerba Pharmaceuticals
Sumant Kulkarni42%
$9 → $11MaintainsBuyGet Alert
05/02/2022CLNNBuy Now
Clene
$4.50122.22%
Sumant Kulkarni42%
→ $200Initiates → BuyGet Alert
04/13/2022GHRSBuy Now
GH Research
$11.78248.05%
Sumant Kulkarni42%
$45 → $41MaintainsBuyGet Alert
03/16/2022ACADBuy Now
ACADIA Pharmaceuticals
$17.2979.29%
Sumant Kulkarni42%
$30 → $31UpgradeHold → BuyGet Alert
03/14/2022CARABuy Now
Cara Therapeutics
$4.01623.19%
Sumant Kulkarni42%
$396 → $348MaintainsBuyGet Alert
02/07/2022BIIBBuy Now
Biogen
$141.43115.65%
Sumant Kulkarni42%
$335 → $305MaintainsBuyGet Alert
01/28/2022CRTXBuy Now
Cortexyme
Sumant Kulkarni42%
DowngradeBuy → HoldGet Alert
12/22/2021ACADBuy Now
ACADIA Pharmaceuticals
$17.2973.51%
Sumant Kulkarni42%
$26 → $30MaintainsHoldGet Alert
09/16/2021CRTXBuy Now
Cortexyme
Sumant Kulkarni42%
$75 → $150MaintainsBuyGet Alert
08/06/2021NBIXBuy Now
Neurocrine Biosciences
$109.71-1.56%
Sumant Kulkarni42%
$122 → $108DowngradeBuy → HoldGet Alert
08/03/2021BHVNBuy Now
Biohaven
$28.75421.74%
Sumant Kulkarni42%
$101 → $150MaintainsBuyGet Alert
07/27/2021SAGEBuy Now
Sage Therapeutics
$8.251063.64%
Sumant Kulkarni42%
$119 → $96MaintainsBuyGet Alert
07/27/2021BIIBBuy Now
Biogen
$141.43199.09%
Sumant Kulkarni42%
$359 → $423MaintainsBuyGet Alert
07/20/2021GHRSBuy Now
GH Research
$11.78197.11%
Sumant Kulkarni42%
→ $35Initiates → BuyGet Alert
05/12/2021ACADBuy Now
ACADIA Pharmaceuticals
$17.2956.16%
Sumant Kulkarni42%
$26 → $27MaintainsHoldGet Alert
04/06/2021ACADBuy Now
ACADIA Pharmaceuticals
$17.2950.38%
Sumant Kulkarni42%
$40 → $26DowngradeBuy → HoldGet Alert
04/01/2021BTAIBuy Now
BioXcel Therapeutics
$2.343959.83%
Sumant Kulkarni42%
$1760 → $1520MaintainsBuyGet Alert
03/09/2021ACADBuy Now
ACADIA Pharmaceuticals
$17.29131.35%
Sumant Kulkarni42%
$61 → $40MaintainsBuyGet Alert
11/16/2020BHVNBuy Now
Biohaven
$28.75282.61%
Sumant Kulkarni42%
$80 → $110MaintainsBuyGet Alert
11/12/2020NBIXBuy Now
Neurocrine Biosciences
$109.7111.2%
Sumant Kulkarni42%
$145 → $122MaintainsBuyGet Alert
08/06/2020ACADBuy Now
ACADIA Pharmaceuticals
$17.29247.02%
Sumant Kulkarni42%
$56 → $60MaintainsBuyGet Alert
08/04/2020NBIXBuy Now
Neurocrine Biosciences
$109.7132.17%
Sumant Kulkarni42%
$134 → $145MaintainsBuyGet Alert
06/10/2020NBIXBuy Now
Neurocrine Biosciences
$109.7122.14%
Sumant Kulkarni42%
$123 → $134MaintainsBuyGet Alert
05/13/2020CRTXBuy Now
Cortexyme
Sumant Kulkarni42%
$42 → $70Reiterates → BuyGet Alert
05/07/2020NBIXBuy Now
Neurocrine Biosciences
$109.7112.11%
Sumant Kulkarni42%
$122 → $123MaintainsBuyGet Alert
04/24/2020BIIBBuy Now
Biogen
$141.43147.47%
Sumant Kulkarni42%
$360 → $350MaintainsBuyGet Alert
04/08/2020SAGEBuy Now
Sage Therapeutics
$8.25869.7%
Sumant Kulkarni42%
$96 → $80MaintainsBuyGet Alert
01/27/2020BIIBBuy Now
Biogen
$141.43154.54%
Sumant Kulkarni42%
→ $360UpgradeHold → BuyGet Alert
11/05/2019NBIXBuy Now
Neurocrine Biosciences
$109.7111.2%
Sumant Kulkarni42%
$120 → $122MaintainsBuyGet Alert
10/23/2019BIIBBuy Now
Biogen
$141.43115.65%
Sumant Kulkarni42%
$285 → $305MaintainsHoldGet Alert
09/17/2019ALDRBuy Now
Alder BioPharmaceuticals
Sumant Kulkarni42%
→ $20DowngradeBuy → HoldGet Alert
09/10/2019ACADBuy Now
ACADIA Pharmaceuticals
$17.29
Sumant Kulkarni42%
UpgradeHold → BuyGet Alert
07/24/2019BIIBBuy Now
Biogen
$141.43101.51%
Sumant Kulkarni42%
$275 → $285MaintainsHoldGet Alert
06/03/2019CRTXBuy Now
Cortexyme
Sumant Kulkarni42%
→ $42Initiates → BuyGet Alert
04/15/2019BHVNBuy Now
Biohaven
$28.75209.57%
Sumant Kulkarni42%
$46 → $89MaintainsBuyGet Alert
03/22/2019BIIBBuy Now
Biogen
$141.4394.44%
Sumant Kulkarni42%
$396 → $275DowngradeBuy → HoldGet Alert
03/14/2019ALDRBuy Now
Alder BioPharmaceuticals
Sumant Kulkarni42%
$21 → $20MaintainsBuyGet Alert
12/10/2018ACADBuy Now
ACADIA Pharmaceuticals
$17.2933.02%
Sumant Kulkarni42%
→ $23Initiates → HoldGet Alert
11/21/2018NBIXBuy Now
Neurocrine Biosciences
$109.711.18%
Sumant Kulkarni42%
→ $111Initiates → BuyGet Alert
08/10/2018ALDRBuy Now
Alder BioPharmaceuticals
Sumant Kulkarni42%
$20 → $22MaintainsBuyGet Alert
07/23/2018BIIBBuy Now
Biogen
$141.43180%
Sumant Kulkarni42%
$335 → $396MaintainsBuyGet Alert
05/31/2018BIIBBuy Now
Biogen
$141.43
Sumant Kulkarni42%
UpgradeHold → BuyGet Alert
03/27/2018BHVNBuy Now
Biohaven
$28.7518.26%
Sumant Kulkarni42%
$39 → $34MaintainsBuyGet Alert
03/15/2018VYGRBuy Now
Voyager Therapeutics
$4.09755.75%
Sumant Kulkarni42%
$36 → $35MaintainsBuyGet Alert
02/28/2018AVXSBuy Now
AveXis
Sumant Kulkarni42%
$110 → $120MaintainsHoldGet Alert
01/24/2018BIIBBuy Now
Biogen
$141.43147.47%
Sumant Kulkarni42%
$340 → $350MaintainsHoldGet Alert
10/27/2017VYGRBuy Now
Voyager Therapeutics
$4.09755.75%
Sumant Kulkarni42%
→ $35Initiates → BuyGet Alert
10/27/2017BIIBBuy Now
Biogen
$141.43140.4%
Sumant Kulkarni42%
→ $340Initiates → HoldGet Alert
10/27/2017AVXSBuy Now
AveXis
Sumant Kulkarni42%
→ $110Initiates → HoldGet Alert
10/27/2017ALDRBuy Now
Alder BioPharmaceuticals
Sumant Kulkarni42%
→ $20Initiates → BuyGet Alert
01/31/2017TEVABuy Now
Teva Pharmaceutical Indus
$16.17
Sumant Kulkarni42%
UpgradeNeutral → BuyGet Alert
11/07/2016TEVABuy Now
Teva Pharmaceutical Indus
$16.17
Sumant Kulkarni42%
DowngradeBuy → NeutralGet Alert
04/01/2013BIIBBuy Now
Biogen
$141.4345.66%
Sumant Kulkarni42%
$200 → $206MaintainsBuyGet Alert
03/28/2013BIIBBuy Now
Biogen
$141.4341.41%
Sumant Kulkarni42%
$187 → $200MaintainsBuyGet Alert
02/27/2013BIIBBuy Now
Biogen
$141.4332.22%
Sumant Kulkarni42%
$163 → $187UpgradeHold → BuyGet Alert
01/03/2013BIIBBuy Now
Biogen
$141.43-1.72%
Sumant Kulkarni42%
$144 → $139MaintainsHoldGet Alert
12/17/2012BIIBBuy Now
Biogen
$141.431.82%
Sumant Kulkarni42%
→ $144Initiates → HoldGet Alert